Woojin Jung

9PUBLICATIONS
18CO-AUTHORS
NeonatologyPharmacogenomicsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Te ariā o ngā tauira panoni hauora o te Māori (Māori theory of change models for health)Biomolecular modelling and design
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|May 12, 2026
Optimal dosing for vascular anomalies paediatric patients with population pharmacokinetic model of sirolimus.

|Jan 16, 2026
A Mechanism-Based Multi-Level Population PK/PD Model for Potassium-Competitive Acid Blockers.

Woojin Jung, Jaeyeon Lee, Hyeseon Jeon

|May 21, 2025
Dose Optimization of rhIL-7-hyFc for Patients With Lymphopenia Using a Neonatal Fc Receptor-Mediated Recycling-Based and Target-Mediated Drug Disposition Pharmacokinetic Model.

Hye Seon Jeon, Sang Won Lee, Woojin Jung

|Apr 18, 2025
Model-Based Meta-Analysis of the Relationship Between Pioglitazone and Histological Outcomes in Metabolic Dysfunction-Associated Steatohepatitis Patients.

Quyen Thi Tran, Tham Thi Bui, Lien Thi Ngo

|Dec 23, 2024
Development of a physiologically-based pharmacokinetic model for Ritonavir characterizing exposure and drug interaction potential at both acute and steady-state conditions.

Lien Thi Ngo, Woojin Jung, Tham Thi Bui

|May 26, 2024
Predicting lung exposure of intramuscular niclosamide as an antiviral agent: Power-law based pharmacokinetic modeling.

Taeheon Kim, Woojin Jung, Sangeun Cho

Pageof 2

Frequent Collaborators

8 joint publications

Hwi-Yeol Yun

6 joint publications

Jung-Woo Chae

4 joint publications

Soyoung Lee

2 joint publications

Hyeseon Jeon